IDEAYA Biosciences Q4 EPS $(0.52) Misses $(0.47) Estimate, Sales $3.92M Miss $8.84M Estimate
Portfolio Pulse from Benzinga Newsdesk
IDEAYA Biosciences (NASDAQ:IDYA) reported Q4 earnings with a loss of $(0.52) per share, missing the $(0.47) estimate, and sales of $3.92M, missing the $8.84M estimate. This represents a decrease in performance compared to the same period last year.
February 20, 2024 | 11:02 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
IDEAYA Biosciences reported a larger than expected quarterly loss and a significant miss in sales estimates for Q4.
Missing both EPS and sales estimates significantly, especially by 55.62% in sales, indicates underperformance that could lead to negative investor sentiment and a potential decrease in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100